Fluoxetine.HCl

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers, 26 USDMF, 15 CEP/COS, 3 EU WC, 28 KDMF, 18 NDC API, 26 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

6 Suppliers

6 Suppliers

DOSSIERs // Finished Dosage Forms

441 Dossiers, 158 FDA Orange Book, 155 Europe, 45 Canada, 12 Australia, 21 South Africa, 50 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 10MG BASE, CAPSULE;ORAL - EQ 20MG BASE, CAPSULE;ORAL - EQ 40MG BASE, TABLET;ORAL - EQ 60MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 33 Kerry, 32 BASF, 22 Roquette, 20 Microlex e.U, 17 SPI Pharma, 16 Seppic, 13 Gangwal Chemicals, 12 Sigachi Industries, 11 Gangwal Healthcare, 10 Corel Pharma Chem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 DKSH, 9 Nanjing Well Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 8 Actylis, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Ideal Cures Pvt Ltd, 6 DFE Pharma, 6 Lonza Capsugel, 5 Ingredion Pharma Solutions, 4 Prachin Chemical, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 Kima Chemical, 4 Pharmatrans-Sanaq, 3 Ulanqab Kema New Material, 3 The Dow Chemical Company, 2 Seqens, 2 Finar, 2 Pfanstiehl, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 2 Qualicaps, 2 Rochem International Inc, 1 Clariant, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Evonik, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Vertellus, 1 Nanjing Bold Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 59 Coating Systems & Additives, 44 Disintegrants & Superdisintegrants, 44 Direct Compression, 36 Thickeners and Stabilizers, 33 Solubilizers, 33 Controlled & Modified Release, 29 Granulation, 23 Parenteral, 22 Topical, 21 Lubricants & Glidants, 20 Film Formers & Plasticizers, 19 Taste Masking, 17 Co-Processed Excipients, 17 Chewable & Orodispersible Aids, 11 Emulsifying Agents, 9 Empty Capsules, 8 API Stability Enhancers, 8 Rheology Modifiers, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 154 Finished Drug Prices

MARKET PLACE

19 APIs, 4 DOSSIERS // FDF

REF. STANDARDS & IMPURITIES

2 BioAnalytical Methods, 3 EDQM, 3 USP, 8 Others

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 53 News

Annual Sales of Fluoxetine HCl reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Fluoxetine.HCl

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers

26 USDMF

15 CEP/COS

3 EU WC

28 KDMF

18 NDC API

26 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

6 Suppliers

DOSSIERs // Finished Dosage Forms

441 Dossiers

158 FDA Orange Book

155 Europe

45 Canada

12 Australia

21 South Africa

50 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 10MG BASE

CAPSULE;ORAL - EQ 20MG BASE

CAPSULE;ORAL - EQ 40MG BASE

TABLET;ORAL - EQ 60MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

33 Kerry

32 BASF

22 Roquette

20 Microlex e.U

17 SPI Pharma

16 Seppic

13 Gangwal Chemicals

12 Sigachi Industries

11 Gangwal Healthcare

10 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 DKSH

9 Nanjing Well Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

8 Actylis

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Ideal Cures Pvt Ltd

6 DFE Pharma

6 Lonza Capsugel

5 Ingredion Pharma Solutions

4 Prachin Chemical

4 Vasa Pharmachem

4 ACG Worldwide

4 Kima Chemical

4 Pharmatrans-Sanaq

3 Ulanqab Kema New Material

3 The Dow Chemical Company

2 Seqens

2 Finar

2 Pfanstiehl

2 Jai Radhe Sales

2 Nomisma Healthcare

2 Qualicaps

2 Rochem International Inc

1 Clariant

1 Shijiazhuang Huaxu Pharmaceutical

1 Evonik

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 90MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons